Almost one third of students at a university in Uganda say that they have been subject to sexual coercion, an experience which was often linked to risky sexual behaviour. This is shown in a study from Lund University in Sweden. The study's findings could lead to a new approach in the work to combat HIV in Uganda. The link between being subjected to sexual coercion and engaging in risky sexual behaviour by making an early sexual debut and having many sexual partners is significant in the work to prevent HIV, in the view of to Anette Agardh, the researcher who has led the study...

A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus, according to the American Psychological Association. "Exclusive reliance on a drug to ...

On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people. The FDA is not obliged to follow the advice of its Antiviral Drugs Advisory Committee, but ...

In order to reduce HIV and TB in African prisons, African governments and international health donors should fund criminal justice reforms, experts from Human Rights Watch say in this week's PLoS Medicine...

An international team led by UC Davis researchers has found that mothers in sub-Saharan Africa could successfully follow a protocol for flash-heating breast milk to reduce transmission of human immunodeficiency virus (HIV) -- the virus that causes AIDS -- to their infants. Flash-heating breast milk is recommended by the World ...

African-Americans with HIV are much less likely to adhere to drug therapy than others with the disease, according to a University of Michigan study. Moreover, untreated depression may greatly hinder adherence to antiretroviral therapy (ART) for all low-income, HIV-infected patients, regardless of race. The study is the first known to ...

UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both ...

HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of ...